You stopped the weekly shot. The chatter about food did not just return. It came back louder than it was before the shot. People type food noise after stopping a GLP-1 because that is the mismatch they cannot shake. We believe you.
Then the kitchen pull returns. And it feels worse than the old baseline, not the same.
We believe you.
Once-weekly semaglutide at 2.4 mg has an elimination half-life of about one week on the U.S. label. After the last 2.4 mg dose, the drug can stay in the blood for about five to seven weeks. Appetite quieting does not vanish the morning you skip a pen. It also does not stay.
Food noise, as researchers now write it, is heightened or persistent food-cue reactivity. Thoughts about food that keep interrupting. Checking the fridge when you are not hungry. Trials of stopping a GLP-1 did not score that chatter with a food-noise scale. They scored weight.
In the STEP 1 extension, 327 adults had been on weekly semaglutide 2.4 mg for 68 weeks. Then the drug and the lifestyle program stopped. Mean loss on treatment was 17.3 percent of body weight. In the next year off treatment they regained 11.6 percentage points. About two thirds of the loss. Blood pressure and similar numbers drifted back toward where they started.
That is what withdrawal looks like on a scale. It is not a character test.
Why food noise after stopping a GLP-1 can feel louder
Weight loss itself changes the hormones that drive hunger. In 2011, researchers followed 50 people after a 10-week very-low-energy diet. Mean loss was 13.5 kg. A year later, ghrelin was still higher than before the diet. Hunger ratings were still higher too. The circulating signals that push you to eat more had not gone back to the old levels.
A GLP-1 can damp some of that push while you take it. When the shot stops, the dampening fades. The body is still lighter than it was, so the defense is still on. The chatter can feel louder than the year you started. You are hearing the defense. You are not hearing the original baseline.
No food-noise trial has proven that louder-than-baseline claim. The hormone data after weight loss still match what people report.
Some people stop in a gap. Cost. A box that never arrived. Nausea nobody walked them through. In a U.S. cohort of 125,474 adults who started a GLP-1 for overweight or obesity, most people without type 2 diabetes had stopped by one year. The share was 64.8 percent. Lower early loss tracked with stopping. So did lower income. So did gastrointestinal side effects. Weight regain tracked with starting again.
If you quit because a program made it hard to stay, the louder noise is still real. The reason you quit still matters for what you do next.
What to bring a licensed provider
Do not restart a high dose on your own after weeks off. Labels and clinics treat a long gap as a reason to step the dose back up. Jumping back to 2.4 mg can make nausea and vomiting worse. Your clinician decides the restart.
Say when the last dose was. Say whether the noise is all day or only at night. Say whether you stopped over money, a side effect, a pause for surgery, or because you thought you were done. Those are different visits.
If you want to stay off, they can still help you plan meals and follow-up while the drug clears. If you want to go back on, ask what the first dose should be after your gap.
Talk to your provider before you skip more doses or change a plan.
Sources
- Hayashi D et al. What Is Food Noise? A Conceptual Model of Food Cue Reactivity. Nutrients. 2023;15(22):4809.
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564.
- U.S. FDA. Semaglutide injection prescribing information. November 2024.
- Sumithran P et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597-1604.
- Rodriguez PJ et al. Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity. JAMA Netw Open. 2025;8(1):e2457349.
See what a Living+ plan costs and whether it fits.
